VALEANT PHARMACEUTICALS INTERNATIONAL
VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) is a publicly traded company in the Unknown sector. Across all available filings, 67 corporate insiders have executed 1000 transactions totaling $2.9B, demonstrating a bearish sentiment with -$1.7B in net insider flow. The most recent transaction on Jun 29, 2018 involved a transaction of 1,344 shares valued at $31.2K.
VRX Insider Activity Summary
Who Is Buying VRX Stock?
No significant insider buying has been recorded for VRX in the recent period.
Who Is Selling VRX Stock?
No significant insider selling has been recorded for VRX in the recent period.
Is VALEANT PHARMACEUTICALS INTERNATIONAL Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VRX is bearish with an Insider Alignment Score of 21/100 and a net flow of -$1.7B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
VRX Frequently Asked Questions
Understanding VRX Insider Activity
Insider trading at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 67 insiders are actively trading VRX stock, having executed 1000 transactions in the past 90 days. The most active insider is Capital Management, L.p. Valueact (Executive), who has made 24 transactions totaling $1.3B.
Related Tools
Track VALEANT PHARMACEUTICALS INTERNATIONAL Insider Activity
Get notified when executives and directors at VRX file new Form 4 transactions